GGrantIndex
Sort

17,828 grants matching crispr

Identifying novel modes of oncogenic signaling in multiple myeloma

$1,160,441
Ryan Young · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Tumor selective inhibition of the WNT pathway

$1,159,628
Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA

The Cancer Target Discovery and Development Network at UCSF

$1,158,875
Michael T McManus · University Of California, San Francisco · U01 · FY2018 · CA

The Investigation of disease causing genes in C. elegans

$1,158,461
Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Regulated energy metabolism in ALS/FTD

$1,157,896
Kristi A Wharton · Brown University · RF1 · FY2022 · NS

iPS-technology and patient specific disease models

$1,156,135
Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL

EDGE FGT: Development of functional genomics tools in cactophilic Drosophila

$1,155,403
Luciano M Matzkin · University Of Arizona · · FY2022 · BIO

NIEHS Knock Out Core (KOC) Annual Report

$1,154,570
Manas Ray · National Institute Of Environmental Health Sciences · ZIC · FY2019 · ES

In vivo investigation of sensory hair cell function and development

$1,153,521
Katherine Kindt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2015 · DC

Neuroimmunological insights into brain development and dysfunction: an integrative approach focused on microglial dynamics

$1,152,000
Lucas M Cheadle · Cold Spring Harbor Laboratory · DP2 · FY2025 · MH

CAREER: Neuropeptidergic control of life cycle transition in Cnidaria

$1,150,000
Nagayasu Nakanishi · University Of Arkansas · · FY2021 · BIO

A cross-species preclinical platform to enhance the translation of new medicines

$1,149,771
Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2025 · TR

Preclinical optimization of a gene therapy for erythromelalgia and chronic pain

$1,149,467
Fernando Aleman Guillen · Navega Therapeutics, Inc. · U44 · FY2023 · NS

A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTION

$1,149,158
Steven Carl George · University Of California At Davis · UG3 · FY2017 · HL

Mechanism, Regulation and Application of miRNA pathway in cancer

$1,149,001
Shuo Gu · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Developing Novel Therapies for High Risk Pediatric Cancers

$1,148,695
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology

$1,147,500
Matthew D Disney · Scripps Florida · R35 · FY2020 · NS

Commercialization of methods and reagents for high-throughput single cell analysis

$1,146,224
Kristina Fontanez · Fluent Biosciences Inc. · R44 · FY2023 · GM

Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia

$1,144,679
Jeffrey Wallace Tyner · Oregon Health & Science University · U01 · FY2023 · CA

Somatic Mosaicism in the Brain of Tourette Syndrome

$1,143,049
Flora M Vaccarino · Yale University · U01 · FY2019 · MH

Investigating mechanisms of bladder tumorigenesis

$1,142,525
Abdul Banday · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer

$1,140,720
Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2023 · CA

Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer

$1,140,720
Reuben J Shaw · Salk Institute For Biological Studies · R35 · FY2022 · CA

RoL:NSF-BSF: IMAGiNE: Temperature acclimation through RNA editing

$1,140,080
Joshua J Rosenthal · Marine Biological Laboratory · · FY2021 · BIO

Programmable RNA-targeting tools

$1,140,080
Feng Zhang · Broad Institute, Inc. · R01 · FY2019 · HG